Benazepril Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 18 USDMF, 8 CEP/COS, 2 JDMF, 7 EU WC, 14 NDC API, 9 Listed Suppliers, $ API Reference Price

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

170 FDF Dossiers, 150 FDA Orange Book, 5 Europe, 8 Canada, 7 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET;ORAL - 20MG, TABLET;ORAL - 40MG, TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 10MG BASE;20MG, CAPSULE;ORAL - EQ 10MG BASE;40MG, CAPSULE;ORAL - EQ 2.5MG BASE;10MG, CAPSULE;ORAL - EQ 5MG BASE;10MG, CAPSULE;ORAL - EQ 5MG BASE;20MG, CAPSULE;ORAL - EQ 5MG BASE;40MG

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 12 DKSH, 8 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 9 Nanjing Well Pharmaceutical, 4 Kirsch Pharma, 4 ACG Worldwide, 6 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 1 Avesta Pharma, 36 BASF, 2 Clariant, 11 Corel Pharma Chem, 6 DFE Pharma, 1 Esteem Industries, 2 Finar, 13 Gangwal Chemicals, 5 Ideal Cures, 3 Ingredion Pharma Solutions, 26 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 20 Roquette, 16 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

65 Fillers, Diluents & Binders, 51 Coating Systems & Additives, 38 Direct Compression, 35 Thickeners and Stabilizers, 34 Granulation, 34 Solubilizers, 32 Disintegrants & Superdisintegrants, 27 Controlled & Modified Release, 25 Lubricants & Glidants, 24 Topical, 19 Parenteral, 19 Film Formers & Plasticizers, 14 Emulsifying Agents, 13 Co-Processed Excipients, 11 Chewable & Orodispersible Aids, 10 Surfactant & Foaming Agents, 9 Empty Capsules, 9 Taste Masking, 7 Rheology Modifiers, 7 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules

DIGITAL CONTENT

4 News #PharmaBuzz

4 News #PharmaBuzz

GLOBAL SALES INFORMATION

6 US Medicaid Prescriptions, 20 Regulatory FDF Prices

MARKET PLACE

2 APIs

2 APIs

PATENTS & EXCLUSIVITIES

5 Health Canada Patents

5 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 1 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 19851 / DOSAGE - TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
BENAZEPRIL HYDROCHLORIDE(UNII: N1SN99T69T) (BENAZEPRILAT - UNII:JRM708L703)	BENAZEPRIL HYDROCHLORIDE	20mg

Inactive Ingredients

Ingredient Name	PD-Rx Pharmaceuticals, Inc.
CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
CROSPOVIDONE(68401960MK)
HYDROGENATED CASTOR OIL(ZF94AP8MEY)
HYPROMELLOSES(3NXW29V3WO)
LACTOSE(J2B2A4N98G)
POLYSORBATE 80(6OZP39ZG8H)
SILICON DIOXIDE(ETJ7Z6XBU4)
STARCH, POTATO(8I089SAH3T)
TALC(7SEV7J4R1U)
TITANIUM DIOXIDE(15FIX9V2JP)

Setid 1b86bd94 7734 4080 8fab 11d226f71a37 Applno 19851 Form Tablet Oral Dosage 5mg - Drug Product Composition: Benazepril Hydrochloride